Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious...Dec 14, 2023, 14:47 ET CSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, Receives FDA and EMA Filing Acceptance Global biotechnolo...
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348)...
We have profited handsomely from the ownership, on behalf of our investors, of CSL (ASX:CSL) in The Montgomery Fund and The Montgomery [Private] Fund, so we are cheering it along as it grows daily in market value. Australian biotech company CSL Limited was founded in 1916 and researches,...